The authors conclude that if digital prescribing is to improve patient safety effectively, significant improvements are necessary. The study’s findings appear in the Feb. 9 problem of the Archives of Internal Medicine. Electronic prescribing obviously will improve medication protection, but its full benefit will not be realized without the advancement and integration of high-quality decision support systems to help clinicians better manage medicine safety alerts, says the study’s senior writer Saul Weingart, MD, PhD, vice president for patient safety at Dana-Farber and an internist at BIDMC.Analysis was conducted based on risk factor according to age groups. For instance, below 60 years, 60 to 69 years, and 70 above and years were categorized into different organizations. Complete data on breasts cancer, bone metastases, and SRE regarding to these age ranges ensured accuracy of the results. Sensitivity analysis helped understand if disease progression actually resulted in changes after an SRE. In other words, scientists covered all certain specific areas before establishing results. Around 2.6 million people survived breast cancer in 2011 across the United States. Early detection of the disease is essential in stopping bone metastasis leading to SRE in the future. Our generic Canadian pharmacy informs around 15 percent women suffering from breast cancer invariably have an associate of the family also diagnosed with the disease.